Non-depleting anti-CD19 B cell inhibition
Nature Reviews Rheumatology, Published online: 03 August 2023; doi:10.1038/s41584-023-01018-zAn antibody that targets CD19 on B cells has shown greater inhibitory efficacy than that of anti-CD20 B cell depletion therapy in animal models of autoimmune diseases.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Robert Phillips Source Type: research
More News: Autoimmune Disease | Rheumatology